Home  |  Contact Us  |  Site Map

Investor Relations

Corporate Profile
Prometheus Laboratories Inc. is a specialty pharmaceutical company committed to developing new ways to help physicians individualize patient care. Prometheus focuses on the treatment, diagnosis and detection of gastrointestinal, autoimmune and inflammatory diseases and disorders. Prometheus’ strategy includes the marketing and delivery of pharmaceutical products complemented by its proprietary, high-value diagnostic testing services. By integrating therapeutics and diagnostic services, Prometheus addresses the continuum of patient care, thereby providing physicians with a comprehensive solution to treat chronic diseases.
Recent NewsMore >>>
05/31/14Printer Friendly VersionPROCLAIMSM National Patient Registry Analysis Shows Improved Median Overall Survival in Patients with Metastatic Melanoma Treated with High-Dose Interleukin-2 (HD IL-2)
05/30/14Printer Friendly VersionPROCLAIMSM Patient Registry Data Show Extension of Overall Survival Benefits Beyond Complete and Partial Responders in Metastatic Renal Cell Carcinoma Patients Treated with High-Dose Interleukin-2 (HD IL-2)
05/05/14Printer Friendly VersionINNOVATIVE PUBLIC-PRIVATE CONSORTIUM ESTABLISHED TO DEFINE THE TRIGGERS OF IBD
Conference Presentations
There are currently no events scheduled.



Home  |   Contact Us  |   Site Map  |   Privacy Policy  |   Legal Notices   |   ProNet
nestle